OQS
EVGN icon

Occudo Quantitative Strategies’s Evogene EVGN Stock Holding History

Occudo Quantitative Strategies’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,583
Closed -$34K – 1207
2022
Q1 		$34K Hold
2,583
– – ﹤0.01% 1089
2021
Q4 		$42K Sell
2,583
-156
-6% -$3.54K ﹤0.01% 1017
2021
Q3 		$72K Sell
2,739
-9
-0.3% -$263 0.01% 947
2021
Q2 		$94K Buy
+2,748
New +$108K 0.01% 795

Other funds holding EVGN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return

Occudo Quantitative Strategies's EVGN Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Evogene (EVGN) in Q2 2022, closing a stake of 2,583 shares — an estimated $34K sold.

Occudo Quantitative Strategies first reported a position in EVGN in Q2 2021 and held it in 4 quarters. The position peaked at $94K in Q2 2021. 29 funds tracked by Wall St. Rank hold EVGN as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining Evogene position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 2,583 Evogene shares in Q2 2022, an estimated $34K.
  • Occudo Quantitative Strategies first reported a position in Evogene in Q2 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Evogene position peaked at $94K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Evogene as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.